DIAGNOS (CVE:ADK) Stock Price Down 1% – Time to Sell?

DIAGNOS Inc. (CVE:ADK) shares fell 1% on Monday. The company traded as low as C$0.47 and last traded at C$0.47. Approximately 126,218 shares changed hands during mid-day trading, a decline of 44% from the average daily volume of 227,176 shares. The stock had previously closed at C$0.48.

DIAGNOS Stock Performance

The firm has a market cap of C$57.49 million, a P/E ratio of -11.88 and a beta of 0.40. The company has a current ratio of 1.49, a quick ratio of 0.68 and a debt-to-equity ratio of 204.05. The company’s 50-day moving average is C$0.42 and its two-hundred day moving average is C$0.30.

Insider Buying and Selling at DIAGNOS

In related news, Director Robert Dunn bought 200,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 29th. The shares were bought at an average price of C$0.30 per share, with a total value of C$60,000.00. Following the completion of the transaction, the director directly owned 2,117,778 shares in the company, valued at approximately C$635,333.40. This represents a 10.43% increase in their ownership of the stock. Insiders purchased a total of 433,571 shares of company stock valued at $146,400 in the last 90 days. 16.81% of the stock is owned by company insiders.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.